These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

401 related articles for article (PubMed ID: 25615716)

  • 1. The impact of molecular dynamics on drug design: applications for the characterization of ligand-macromolecule complexes.
    Mortier J; Rakers C; Bermudez M; Murgueitio MS; Riniker S; Wolber G
    Drug Discov Today; 2015 Jun; 20(6):686-702. PubMed ID: 25615716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular modeling of hydration in drug design.
    Mancera RL
    Curr Opin Drug Discov Devel; 2007 May; 10(3):275-80. PubMed ID: 17554853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lead optimization via high-throughput molecular docking.
    Joseph-McCarthy D; Baber JC; Feyfant E; Thompson DC; Humblet C
    Curr Opin Drug Discov Devel; 2007 May; 10(3):264-74. PubMed ID: 17554852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of Protein-Ligand Binding Poses via a Combination of Induced Fit Docking and Metadynamics Simulations.
    Clark AJ; Tiwary P; Borrelli K; Feng S; Miller EB; Abel R; Friesner RA; Berne BJ
    J Chem Theory Comput; 2016 Jun; 12(6):2990-8. PubMed ID: 27145262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advancements in Docking and Molecular Dynamics Simulations Towards Ligand-receptor Interactions and Structure-function Relationships.
    Naqvi AAT; Mohammad T; Hasan GM; Hassan MI
    Curr Top Med Chem; 2018; 18(20):1755-1768. PubMed ID: 30360721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physics-based methods for studying protein-ligand interactions.
    Huang N; Jacobson MP
    Curr Opin Drug Discov Devel; 2007 May; 10(3):325-31. PubMed ID: 17554859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How Docking Programs Work.
    Bitencourt-Ferreira G; de Azevedo WF
    Methods Mol Biol; 2019; 2053():35-50. PubMed ID: 31452097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A structure-differential binding method for elucidating the interactions between flavonoids and cytochrome-c by ESI-MS and molecular docking.
    Wang X; Liu Y; Wang H
    Talanta; 2013 Nov; 116():368-75. PubMed ID: 24148417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Informatics and modeling challenges in fragment-based drug discovery.
    Hubbard RE; Chen I; Davis B
    Curr Opin Drug Discov Devel; 2007 May; 10(3):289-97. PubMed ID: 17554855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rational Modification of the Biological Profile of GPCR Ligands through Combination with Other Biologically Active Moieties.
    Huang G; Nimczick M; Decker M
    Arch Pharm (Weinheim); 2015 Aug; 348(8):531-40. PubMed ID: 25941009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pocket extraction on proteins via the Voronoi diagram of spheres.
    Kim D; Cho CH; Cho Y; Ryu J; Bhak J; Kim DS
    J Mol Graph Model; 2008 Apr; 26(7):1104-12. PubMed ID: 18023220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can We Rely on Computational Predictions To Correctly Identify Ligand Binding Sites on Novel Protein Drug Targets? Assessment of Binding Site Prediction Methods and a Protocol for Validation of Predicted Binding Sites.
    Broomhead NK; Soliman ME
    Cell Biochem Biophys; 2017 Mar; 75(1):15-23. PubMed ID: 27796788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Editorial preface.
    Nilsson L; Åqvist J
    Biochim Biophys Acta; 2015 May; 1850(5):859-860. PubMed ID: 25615536
    [No Abstract]   [Full Text] [Related]  

  • 14. Computational chemistry approaches to drug discovery in signal transduction.
    Fischer PM
    Biotechnol J; 2008 Apr; 3(4):452-70. PubMed ID: 18412174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The feasibility of an efficient drug design method with high-performance computers.
    Yamashita T; Ueda A; Mitsui T; Tomonaga A; Matsumoto S; Kodama T; Fujitani H
    Chem Pharm Bull (Tokyo); 2015; 63(3):147-55. PubMed ID: 25757485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CHARMM additive and polarizable force fields for biophysics and computer-aided drug design.
    Vanommeslaeghe K; MacKerell AD
    Biochim Biophys Acta; 2015 May; 1850(5):861-871. PubMed ID: 25149274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ranking poses in structure-based lead discovery and optimization: current trends in scoring function development.
    Rajamani R; Good AC
    Curr Opin Drug Discov Devel; 2007 May; 10(3):308-15. PubMed ID: 17554857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MDFit: automated molecular simulations workflow enables high throughput assessment of ligands-protein dynamics.
    Brueckner AC; Shields B; Kirubakaran P; Suponya A; Panda M; Posy SL; Johnson S; Lakkaraju SK
    J Comput Aided Mol Des; 2024 Jul; 38(1):24. PubMed ID: 39014286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein structure-based drug design: from docking to molecular dynamics.
    Śledź P; Caflisch A
    Curr Opin Struct Biol; 2018 Feb; 48():93-102. PubMed ID: 29149726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydration properties of ligands and drugs in protein binding sites: tightly-bound, bridging water molecules and their effects and consequences on molecular design strategies.
    García-Sosa AT
    J Chem Inf Model; 2013 Jun; 53(6):1388-405. PubMed ID: 23662606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.